Our recent study has reported that MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/beta-catenin signaling pathway [9]. The gene discussed is MACC1; the disease is nasopharyngeal carcinoma.